|Tested species reactivity||Dog, Cat, Guinea pig, Mouse, Non-human primate, Pig, Rabbit, Rat|
|Published species reactivity||Rat, Human, Mouse|
|Host / Isotype||Mouse / IgG1|
|Clone||B314.1 (MAC 387)|
|Immunogen||Affinity purified monocyte membrance preparation.|
|Storage buffer||PBS, pH 7.2|
|Storage Conditions||4° C, do not freeze|
|Tested Applications||Dilution *|
|Immunohistochemistry (Paraffin) (IHC (P))||1:50-1:100|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
|Immunohistochemistry (IHC)||See 3 publications below|
MA1-91321 detects S100A8 from mouse, rat, canine, porcine, non-human primate, rabbit, feline and guinea pig samples.
MA1-91321 has been successfully used in immunohistochemistry (paraffin tissue) applications.
The MA1-91321 immunogen is: Affinity purified monocyte membrance preparation.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Xenotransplantation of human unrestricted somatic stem cells in a pig model of acute myocardial infarction.
MA1-91321 was used in immunohistochemistry to study whether xenotransplantation with human CD34-/CD45- unrestricted somatic stem cells is of therapeutic benefit in a porcine model of acute myocardial infarction
|Gahremanpour A,Vela D,Zheng Y,Silva GV,Fodor W,Cardoso CO,Baimbridge F,Fernandes MR,Buja LM,Perin EC||Xenotransplantation (20:110)||2013|
Controlled release of chitosan/heparin nanoparticle-delivered VEGF enhances regeneration of decellularized tissue-engineered scaffolds.
MA1-91321 was used in immunohistochemistry to develop a novel VEGF release strategy to enable tissue-engineering scaffold regeneration
|Tan Q,Tang H,Hu J,Hu Y,Zhou X,Tao Y,Wu Z||International journal of nanomedicine (6:929)||2011|
Decellularized, xenogeneic small-diameter arteries: transition from a muscular to an elastic phenotype in vivo.
MA1-91321 was used in immunohistochemistry to study the long term biocompatibility of xenogeneic, decellularized bioprosthetic implants in a rat model
|Bergmeister H,Plasenzotti R,Walter I,Plass C,Bastian F,Rieder E,Sipos W,Kaider A,Losert U,Weigel G||Journal of biomedical materials research. Part B, Applied biomaterials (87:95)||2008|